LEPU BIO-B (02157) Sets 25 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal

Bulletin Express

Mar 11

LEPU BIOPHARMA CO., LTD. (LEPU BIO-B, 02157) has scheduled a board meeting for 25 March 2026. Directors will examine and approve the consolidated financial statements for the year ended 31 December 2025, consider the declaration of a final dividend, and handle other routine matters.

The meeting will be chaired by Dr. Pu Zhongjie, who serves as both Chairman and Executive Director. The current board consists of two executive directors (Dr. Pu Zhongjie and CEO Dr. Sui Ziye), two non-executive directors (Ms. Pu Jue and Ms. Qin Yiran), and three independent non-executive directors (Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua).

The announcement was released from Shanghai on 11 March 2026. No further financial metrics or dividend figures were disclosed ahead of the scheduled meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1161759806"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161759806\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1161759806?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-11 21:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161759806","market":"hk","top_or_hot":-1,"title":"LEPU BIO-B (02157) Sets 25 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal","media":"Bulletin Express","content":"<p>LEPU BIOPHARMA CO., LTD. (LEPU BIO-B, 02157) has scheduled a board meeting for 25 March 2026. Directors will examine and approve the consolidated financial statements for the year ended 31 December 2025, consider the declaration of a final dividend, and handle other routine matters.</p>\n<p>The meeting will be chaired by Dr. Pu Zhongjie, who serves as both Chairman and Executive Director. The current board consists of two executive directors (Dr. Pu Zhongjie and CEO Dr. Sui Ziye), two non-executive directors (Ms. Pu Jue and Ms. Qin Yiran), and three independent non-executive directors (Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua).</p>\n<p>The announcement was released from Shanghai on 11 March 2026. No further financial metrics or dividend figures were disclosed ahead of the scheduled meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEPU BIO-B (02157) Sets 25 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEPU BIO-B (02157) Sets 25 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-11 21:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LEPU BIOPHARMA CO., LTD. (LEPU BIO-B, 02157) has scheduled a board meeting for 25 March 2026. Directors will examine and approve the consolidated financial statements for the year ended 31 December 2025, consider the declaration of a final dividend, and handle other routine matters.</p>\n<p>The meeting will be chaired by Dr. Pu Zhongjie, who serves as both Chairman and Executive Director. The current board consists of two executive directors (Dr. Pu Zhongjie and CEO Dr. Sui Ziye), two non-executive directors (Ms. Pu Jue and Ms. Qin Yiran), and three independent non-executive directors (Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua).</p>\n<p>The announcement was released from Shanghai on 11 March 2026. No further financial metrics or dividend figures were disclosed ahead of the scheduled meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02157","symbol_name":"乐普生物-B","start_time":0,"source_url":"","article_id":"1161759806","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161759806","pubTimestamp":1773234193,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"LEPU BIOPHARMA CO., LTD. (LEPU BIO-B, 02157) has scheduled a board meeting for 25 March 2026. Directors will examine and approve the consolidated financial statements for the year ended 31 December...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02157":"乐普生物-B"},"translate_title":"乐普生物-B(02157)定于2026年3月25日召开董事会会议，审阅2025财年业绩及末期股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02157":1},"content_text":"LEPU BIOPHARMA CO., LTD. (LEPU BIO-B, 02157) has scheduled a board meeting for 25 March 2026. Directors will examine and approve the consolidated financial statements for the year ended 31 December 2025, consider the declaration of a final dividend, and handle other routine matters.\nThe meeting will be chaired by Dr. Pu Zhongjie, who serves as both Chairman and Executive Director. The current board consists of two executive directors (Dr. Pu Zhongjie and CEO Dr. Sui Ziye), two non-executive directors (Ms. Pu Jue and Ms. Qin Yiran), and three independent non-executive directors (Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua).\nThe announcement was released from Shanghai on 11 March 2026. No further financial metrics or dividend figures were disclosed ahead of the scheduled meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}